{"metadata":{"kernelspec":{"language":"python","display_name":"Python 3","name":"python3"},"language_info":{"name":"python","version":"3.11.13","mimetype":"text/x-python","codemirror_mode":{"name":"ipython","version":3},"pygments_lexer":"ipython3","nbconvert_exporter":"python","file_extension":".py"}},"nbformat_minor":4,"nbformat":4,"cells":[{"cell_type":"code","source":"import os\nfrom kaggle_secrets import UserSecretsClient\n\ntry:\n    GOOGLE_API_KEY = UserSecretsClient().get_secret(\"GOOGLE_API_KEY\")\n    os.environ[\"GOOGLE_API_KEY\"] = GOOGLE_API_KEY\n    print(\"‚úÖ Gemini API key setup complete.\")\nexcept Exception as e:\n    print(\n        f\"üîë Authentication Error: Please make sure you have added 'GOOGLE_API_KEY' to your Kaggle secrets. Details: {e}\"\n    )","metadata":{"_uuid":"8f2839f25d086af736a60e9eeb907d3b93b6e0e5","_cell_guid":"b1076dfc-b9ad-4769-8c92-a6c4dae69d19","trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:53:07.899789Z","iopub.execute_input":"2025-11-12T08:53:07.900078Z","iopub.status.idle":"2025-11-12T08:53:08.059718Z","shell.execute_reply.started":"2025-11-12T08:53:07.900055Z","shell.execute_reply":"2025-11-12T08:53:08.058714Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Gemini API key setup complete.\n","output_type":"stream"}],"execution_count":1},{"cell_type":"code","source":"from typing import Any, Dict\n\nfrom google.adk.agents import Agent, LlmAgent\nfrom google.adk.apps.app import App, EventsCompactionConfig\nfrom google.adk.models.google_llm import Gemini\nfrom google.adk.sessions import DatabaseSessionService\nfrom google.adk.sessions import InMemorySessionService\nfrom google.adk.runners import Runner\nfrom google.adk.tools.tool_context import ToolContext\nfrom google.genai import types\n\nprint(\"‚úÖ ADK components imported successfully.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:53:08.061326Z","iopub.execute_input":"2025-11-12T08:53:08.061675Z","iopub.status.idle":"2025-11-12T08:53:47.069044Z","shell.execute_reply.started":"2025-11-12T08:53:08.061649Z","shell.execute_reply":"2025-11-12T08:53:47.068281Z"}},"outputs":[{"name":"stdout","text":"‚úÖ ADK components imported successfully.\n","output_type":"stream"}],"execution_count":2},{"cell_type":"code","source":"# Define helper functions that will be reused throughout the notebook\nasync def run_session(\n    runner_instance: Runner,\n    user_queries: list[str] | str = None,\n    session_name: str = \"default\",\n):\n    print(f\"\\n ### Session: {session_name}\")\n\n    # Get app name from the Runner\n    app_name = runner_instance.app_name\n\n    # Attempt to create a new session or retrieve an existing one\n    try:\n        session = await session_service.create_session(\n            app_name=app_name, user_id=USER_ID, session_id=session_name\n        )\n    except:\n        session = await session_service.get_session(\n            app_name=app_name, user_id=USER_ID, session_id=session_name\n        )\n\n    # Process queries if provided\n    if user_queries:\n        # Convert single query to list for uniform processing\n        if type(user_queries) == str:\n            user_queries = [user_queries]\n\n        # Process each query in the list sequentially\n        for query in user_queries:\n            print(f\"\\nUser > {query}\")\n\n            # Convert the query string to the ADK Content format\n            query = types.Content(role=\"user\", parts=[types.Part(text=query)])\n\n            # Stream the agent's response asynchronously\n            async for event in runner_instance.run_async(\n                user_id=USER_ID, session_id=session.id, new_message=query\n            ):\n                # Check if the event contains valid content\n                if event.content and event.content.parts:\n                    # Filter out empty or \"None\" responses before printing\n                    if (\n                        event.content.parts[0].text != \"None\"\n                        and event.content.parts[0].text\n                    ):\n                        print(f\"{MODEL_NAME} > \", event.content.parts[0].text)\n    else:\n        print(\"No queries!\")\n\n\nprint(\"‚úÖ Helper functions defined.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:53:47.069852Z","iopub.execute_input":"2025-11-12T08:53:47.070981Z","iopub.status.idle":"2025-11-12T08:53:47.080441Z","shell.execute_reply.started":"2025-11-12T08:53:47.070957Z","shell.execute_reply":"2025-11-12T08:53:47.078982Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Helper functions defined.\n","output_type":"stream"}],"execution_count":3},{"cell_type":"code","source":"retry_config = types.HttpRetryOptions(\n    attempts=5,  # Maximum retry attempts\n    exp_base=7,  # Delay multiplier\n    initial_delay=1,\n    http_status_codes=[429, 500, 503, 504],  # Retry on these HTTP errors\n)\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:53:47.083260Z","iopub.execute_input":"2025-11-12T08:53:47.083688Z","iopub.status.idle":"2025-11-12T08:53:47.230186Z","shell.execute_reply.started":"2025-11-12T08:53:47.083663Z","shell.execute_reply":"2025-11-12T08:53:47.229208Z"}},"outputs":[],"execution_count":4},{"cell_type":"code","source":"APP_NAME = \"default\"  # Application\nUSER_ID = \"default\"  # User\nSESSION = \"default\"  # Session\n\nMODEL_NAME = \"gemini-2.5-flash-lite\"\n\n\n# Step 1: Create the LLM Agent\nroot_agent = Agent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot\",  # Description of the agent's purpose\n)\n\n# Step 2: Set up Session Management\n# InMemorySessionService stores conversations in RAM (temporary)\nsession_service = InMemorySessionService()\n\n# Step 3: Create the Runner\nrunner = Runner(agent=root_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"‚úÖ Stateful agent initialized!\")\nprint(f\"   - Application: {APP_NAME}\")\nprint(f\"   - User: {USER_ID}\")\nprint(f\"   - Using: {session_service.__class__.__name__}\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:53:47.231152Z","iopub.execute_input":"2025-11-12T08:53:47.231439Z","iopub.status.idle":"2025-11-12T08:53:47.247686Z","shell.execute_reply.started":"2025-11-12T08:53:47.231404Z","shell.execute_reply":"2025-11-12T08:53:47.246949Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Stateful agent initialized!\n   - Application: default\n   - User: default\n   - Using: InMemorySessionService\n","output_type":"stream"}],"execution_count":5},{"cell_type":"code","source":"# Run a conversation with two queries in the same session\n# Notice: Both queries are part of the SAME session, so context is maintained\nawait run_session(\n    runner,\n    [\n        \"Hi, I am Sam! What is the capital of United States?\",\n        \"Hello! What is my name?\",  # This time, the agent should remember!\n    ],\n    \"stateful-agentic-session\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:53:47.248549Z","iopub.execute_input":"2025-11-12T08:53:47.248769Z","iopub.status.idle":"2025-11-12T08:53:48.762496Z","shell.execute_reply.started":"2025-11-12T08:53:47.248752Z","shell.execute_reply":"2025-11-12T08:53:48.761563Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: stateful-agentic-session\n\nUser > Hi, I am Sam! What is the capital of United States?\ngemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":6},{"cell_type":"code","source":"# Run this cell after restarting the kernel. All this history will be gone...\nawait run_session(\n    runner,\n    [\"What did I ask you about earlier?\", \"And remind me, what's my name?\"],\n    \"stateful-agentic-session\",\n)  # Note, we are using same session name\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:53:48.763483Z","iopub.execute_input":"2025-11-12T08:53:48.763805Z","iopub.status.idle":"2025-11-12T08:53:49.741689Z","shell.execute_reply.started":"2025-11-12T08:53:48.763785Z","shell.execute_reply":"2025-11-12T08:53:49.740895Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: stateful-agentic-session\n\nUser > What did I ask you about earlier?\ngemini-2.5-flash-lite >  You asked me about the capital of the United States.\n\nUser > And remind me, what's my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":7},{"cell_type":"code","source":"# Step 1: Create the same agent (notice we use LlmAgent this time)\nchatbot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot with persistent memory\",\n)\n\n# Step 2: Switch to DatabaseSessionService\n# SQLite database will be created automatically\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Step 3: Create a new runner with persistent storage\nrunner = Runner(agent=chatbot_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"‚úÖ Upgraded to persistent sessions!\")\nprint(f\"   - Database: my_agent_data.db\")\nprint(f\"   - Sessions will survive restarts!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:53:49.742450Z","iopub.execute_input":"2025-11-12T08:53:49.742699Z","iopub.status.idle":"2025-11-12T08:53:49.833033Z","shell.execute_reply.started":"2025-11-12T08:53:49.742680Z","shell.execute_reply":"2025-11-12T08:53:49.832295Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Upgraded to persistent sessions!\n   - Database: my_agent_data.db\n   - Sessions will survive restarts!\n","output_type":"stream"}],"execution_count":8},{"cell_type":"code","source":"# Step 1: Create the same agent (notice we use LlmAgent this time)\nchatbot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot with persistent memory\",\n)\n\n# Step 2: Switch to DatabaseSessionService\n# SQLite database will be created automatically\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Step 3: Create a new runner with persistent storage\nrunner = Runner(agent=chatbot_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"‚úÖ Upgraded to persistent sessions!\")\nprint(f\"   - Database: my_agent_data.db\")\nprint(f\"   - Sessions will survive restarts!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:54:49.836131Z","iopub.execute_input":"2025-11-12T08:54:49.836866Z","iopub.status.idle":"2025-11-12T08:54:49.844741Z","shell.execute_reply.started":"2025-11-12T08:54:49.836841Z","shell.execute_reply":"2025-11-12T08:54:49.843926Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Upgraded to persistent sessions!\n   - Database: my_agent_data.db\n   - Sessions will survive restarts!\n","output_type":"stream"}],"execution_count":9},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"Hi, I am Sam! What is the capital of the United States?\", \"Hello! What is my name?\"],\n    \"test-db-session-01\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:55:08.634412Z","iopub.execute_input":"2025-11-12T08:55:08.635097Z","iopub.status.idle":"2025-11-12T08:55:09.866307Z","shell.execute_reply.started":"2025-11-12T08:55:08.635071Z","shell.execute_reply":"2025-11-12T08:55:09.865568Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-01\n\nUser > Hi, I am Sam! What is the capital of the United States?\ngemini-2.5-flash-lite >  Hello Sam! The capital of the United States is Washington, D.C.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":10},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"What is the capital of India?\", \"Hello! What is my name?\"],\n    \"test-db-session-01\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:55:24.393941Z","iopub.execute_input":"2025-11-12T08:55:24.394750Z","iopub.status.idle":"2025-11-12T08:55:25.494622Z","shell.execute_reply.started":"2025-11-12T08:55:24.394723Z","shell.execute_reply":"2025-11-12T08:55:25.493866Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-01\n\nUser > What is the capital of India?\ngemini-2.5-flash-lite >  The capital of India is New Delhi.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":11},{"cell_type":"code","source":"await run_session(\n    runner, [\"Hello! What is my name?\"], \"test-db-session-02\"\n)  # Note, we are using new session name","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:55:40.439682Z","iopub.execute_input":"2025-11-12T08:55:40.440445Z","iopub.status.idle":"2025-11-12T08:55:41.049073Z","shell.execute_reply.started":"2025-11-12T08:55:40.440419Z","shell.execute_reply":"2025-11-12T08:55:41.048165Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-02\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  I do not have access to your personal information, including your name. I am a text-based AI and do not store or recall user data.\n","output_type":"stream"}],"execution_count":12},{"cell_type":"code","source":"import sqlite3\n\ndef check_data_in_db():\n    with sqlite3.connect(\"my_agent_data.db\") as connection:\n        cursor = connection.cursor()\n        result = cursor.execute(\n            \"select app_name, session_id, author, content from events\"\n        )\n        print([_[0] for _ in result.description])\n        for each in result.fetchall():\n            print(each)\n\n\ncheck_data_in_db()","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:55:57.852676Z","iopub.execute_input":"2025-11-12T08:55:57.853374Z","iopub.status.idle":"2025-11-12T08:55:57.859581Z","shell.execute_reply.started":"2025-11-12T08:55:57.853350Z","shell.execute_reply":"2025-11-12T08:55:57.858670Z"}},"outputs":[{"name":"stdout","text":"['app_name', 'session_id', 'author', 'content']\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hi, I am Sam! What is the capital of the United States?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Hello Sam! The capital of the United States is Washington, D.C.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"What is the capital of India?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"The capital of India is New Delhi.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-02', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-02', 'text_chat_bot', '{\"parts\": [{\"text\": \"I do not have access to your personal information, including your name. I am a text-based AI and do not store or recall user data.\"}], \"role\": \"model\"}')\n","output_type":"stream"}],"execution_count":13},{"cell_type":"code","source":"# Re-define our app with Events Compaction enabled\nresearch_app_compacting = App(\n    name=\"research_app_compacting\",\n    root_agent=chatbot_agent,\n    # This is the new part!\n    events_compaction_config=EventsCompactionConfig(\n        compaction_interval=3,  # Trigger compaction every 3 invocations\n        overlap_size=1,  # Keep 1 previous turn for context\n    ),\n)\n\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Create a new runner for our upgraded app\nresearch_runner_compacting = Runner(\n    app=research_app_compacting, session_service=session_service\n)\n\n\nprint(\"‚úÖ Research App upgraded with Events Compaction!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:56:24.161083Z","iopub.execute_input":"2025-11-12T08:56:24.161968Z","iopub.status.idle":"2025-11-12T08:56:24.169706Z","shell.execute_reply.started":"2025-11-12T08:56:24.161943Z","shell.execute_reply":"2025-11-12T08:56:24.168853Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Research App upgraded with Events Compaction!\n","output_type":"stream"},{"name":"stderr","text":"/tmp/ipykernel_48/3773147741.py:6: UserWarning: [EXPERIMENTAL] EventsCompactionConfig: This feature is experimental and may change or be removed in future versions without notice. It may introduce breaking changes at any time.\n  events_compaction_config=EventsCompactionConfig(\n","output_type":"stream"}],"execution_count":14},{"cell_type":"code","source":"# Turn 1\nawait run_session(\n    research_runner_compacting,\n    \"What is the latest news about AI in healthcare?\",\n    \"compaction_demo\",\n)\n\n# Turn 2\nawait run_session(\n    research_runner_compacting,\n    \"Are there any new developments in drug discovery?\",\n    \"compaction_demo\",\n)\n\n# Turn 3 - Compaction should trigger after this turn!\nawait run_session(\n    research_runner_compacting,\n    \"Tell me more about the second development you found.\",\n    \"compaction_demo\",\n)\n\n# Turn 4\nawait run_session(\n    research_runner_compacting,\n    \"Who are the main companies involved in that?\",\n    \"compaction_demo\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:56:55.940476Z","iopub.execute_input":"2025-11-12T08:56:55.940766Z","iopub.status.idle":"2025-11-12T08:57:15.890750Z","shell.execute_reply.started":"2025-11-12T08:56:55.940748Z","shell.execute_reply":"2025-11-12T08:57:15.889881Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: compaction_demo\n\nUser > What is the latest news about AI in healthcare?\ngemini-2.5-flash-lite >  Here's a summary of the latest news and trends in AI in healthcare, focusing on recent developments and ongoing impacts:\n\n**Key Areas of Advancement and Recent News:**\n\n*   **Drug Discovery and Development:**\n    *   **Accelerated Timelines:** AI continues to be a game-changer, significantly shortening the time it takes to identify potential drug candidates, predict their efficacy, and optimize clinical trial design. Companies are reporting breakthroughs in identifying novel drug targets and designing molecules for conditions ranging from cancer to neurodegenerative diseases.\n    *   **Personalized Medicine:** AI is crucial in analyzing vast genomic and patient data to tailor drug treatments to individual patients, predicting who will respond best to which therapies and minimizing adverse reactions.\n*   **Diagnostic Imaging and Pathology:**\n    *   **Enhanced Accuracy and Speed:** AI algorithms are becoming increasingly sophisticated at analyzing medical images (X-rays, CT scans, MRIs) to detect subtle anomalies that human eyes might miss. This is particularly impactful in radiology and pathology, aiding in earlier and more accurate diagnoses of conditions like cancer, diabetic retinopathy, and cardiovascular diseases.\n    *   **AI-Powered Tools for Radiologists:** New AI tools are emerging that assist radiologists by prioritizing urgent cases, flagging potential findings, and even performing preliminary analyses, freeing up expert time for more complex interpretations.\n*   **Predictive Analytics and Early Disease Detection:**\n    *   **Forecasting Patient Risk:** AI models are being used to predict a patient's risk of developing certain diseases (e.g., sepsis, heart failure, hospital readmission) based on their electronic health records (EHRs), vital signs, and other data. This allows for proactive interventions and preventative care.\n    *   **Outbreak Prediction:** AI is also being employed to track and predict the spread of infectious diseases by analyzing various data sources, including social media, news reports, and travel patterns.\n*   **AI-Powered Virtual Assistants and Chatbots:**\n    *   **Patient Engagement and Support:** AI-driven chatbots are becoming more prevalent for answering patient questions, scheduling appointments, providing medication reminders, and offering basic health advice, improving accessibility and efficiency.\n    *   **Clinical Workflow Support:** These tools can also assist clinicians by summarizing patient information, drafting clinical notes, and providing relevant medical literature.\n*   **Robotics and Surgical Assistance:**\n    *   **Enhanced Precision in Surgery:** AI is being integrated into robotic surgical systems to improve precision, dexterity, and navigation during complex procedures. This can lead to less invasive surgeries, faster recovery times, and improved patient outcomes.\n    *   **Pre-operative Planning:** AI can create detailed 3D models from imaging data to help surgeons plan procedures with greater accuracy.\n*   **Administrative Efficiency and Operational Optimization:**\n    *   **Automating Tasks:** AI is being used to automate administrative tasks like billing, coding, and appointment scheduling, reducing burnout among healthcare staff and improving operational efficiency.\n    *   **Resource Management:** AI can optimize hospital resource allocation, predicting patient flow and staffing needs.\n\n**Recent Trends and Considerations:**\n\n*   **Regulatory Scrutiny and Ethical Guidelines:** As AI in healthcare becomes more widespread, regulatory bodies (like the FDA) are increasingly focusing on ensuring the safety, efficacy, and fairness of AI-powered medical devices and software. Ethical considerations around data privacy, bias, and accountability are paramount.\n*   **Data Interoperability and Standardization:** A significant challenge remains in integrating AI systems with diverse healthcare data sources. Efforts towards greater data interoperability and standardization are crucial for AI's full potential to be realized.\n*   **Clinician Adoption and Trust:** While AI shows immense promise, gaining the trust and adoption of healthcare professionals is key. Education, transparent AI design, and demonstrating tangible benefits are important factors.\n*   **Focus on Explainable AI (XAI):** There's a growing demand for AI models that can explain their reasoning and decision-making processes, especially in critical healthcare applications where understanding the \"why\" is essential.\n*   **AI for Mental Health:** AI is increasingly being explored for its potential in diagnosing, monitoring, and even treating mental health conditions through tools like sentiment analysis of text and voice, and personalized therapeutic interventions.\n\n**To get the very latest, I'd recommend checking sources like:**\n\n*   **Reputable Medical Journals:** JAMA, The Lancet, Nature Medicine, NEJM.\n*   **Healthcare Technology News Sites:** FierceHealthcare, HIMSS, MedTech Dive.\n*   **Major Tech Company Announcements:** Google Health, Microsoft Healthcare, NVIDIA Healthcare.\n*   **Conferences and Reports:** HIMSS, RSNA, and reports from major consulting firms in healthcare.\n\nThe field is moving incredibly fast, with new research and applications emerging constantly!\n\n ### Session: compaction_demo\n\nUser > Are there any new developments in drug discovery?\ngemini-2.5-flash-lite >  Yes, there are continuous and exciting new developments in drug discovery, largely fueled by advancements in AI and other cutting-edge technologies. Here are some of the most prominent recent trends and breakthroughs:\n\n**1. AI and Machine Learning Dominance:**\n\n*   **Generative AI for Molecule Design:** This is a major area of focus. Instead of just screening existing compounds, AI models are now capable of *generating novel molecular structures* that are predicted to have specific therapeutic properties. This is akin to AI designing a drug from scratch. Companies are using techniques like generative adversarial networks (GANs) and variational autoencoders (VAEs) for this.\n*   **Predictive Modeling for Efficacy and Toxicity:** AI is getting much better at predicting how a potential drug will perform in biological systems *before* it reaches costly and time-consuming lab experiments or clinical trials. This includes predicting binding affinity to targets, absorption, distribution, metabolism, and excretion (ADME) properties, and potential toxic side effects.\n*   **Optimizing Clinical Trial Design:** AI is being used to identify the most suitable patient populations for trials, predict potential drop-out rates, and even help design more efficient trial protocols, thereby speeding up the path to market.\n*   **Deconvoluting Complex Biological Pathways:** AI can analyze vast amounts of 'omics' data (genomics, proteomics, metabolomics) to identify previously unknown disease mechanisms and pinpoint new drug targets.\n\n**2. Advances in Target Identification:**\n\n*   **Undruggable Targets:** A significant effort is underway to develop drugs for targets that were previously considered \"undruggable\" due to their structure or location. AI and novel chemical modalities are helping to overcome these challenges.\n*   **Personalized Targets:** As our understanding of individual genetic variations grows, AI is helping to identify targets specific to certain patient subgroups or even individuals, paving the way for hyper-personalized medicines.\n\n**3. New Modalities Beyond Small Molecules and Antibodies:**\n\n*   **RNA Therapeutics:** Beyond mRNA vaccines, researchers are exploring messenger RNA (mRNA) and small interfering RNA (siRNA) for a wider range of therapeutic applications, targeting diseases at the genetic level.\n*   **Gene Editing (CRISPR):** While still in its early stages for widespread drug development, CRISPR-based therapies are showing immense promise for treating genetic diseases by directly correcting faulty genes.\n*   **Peptide Therapeutics:** Peptides, which are shorter chains of amino acids than proteins, are emerging as a promising class of drugs with good specificity and reduced immunogenicity compared to antibodies.\n*   **PROTACs and Molecular Glues:** These innovative technologies create molecules that \"hijack\" the cell's own protein degradation machinery to eliminate disease-causing proteins. This offers a new way to tackle previously intractable targets.\n\n**4. Automation and High-Throughput Screening:**\n\n*   **Robotic Labs:** Automated laboratories are becoming more sophisticated, allowing for the rapid screening of millions of compounds and the execution of complex experiments with minimal human intervention.\n*   **Organoids and Lab-Grown Tissues:** Using 3D organoids (mini-organs grown in a lab) and other complex tissue models provides more realistic environments for testing drug candidates, leading to more accurate predictions of efficacy and toxicity compared to traditional 2D cell cultures.\n\n**5. Focus on Specific Disease Areas:**\n\n*   **Oncology:** Continues to be a major driver, with AI and new modalities enabling the development of more targeted cancer therapies, immunotherapies, and treatments for rare or previously untreatable cancers.\n*   **Neurodegenerative Diseases:** Significant investment and research are going into finding treatments for Alzheimer's, Parkinson's, and ALS, with AI playing a role in understanding complex disease mechanisms.\n*   **Infectious Diseases:** The pandemic has spurred innovation in rapid drug discovery for novel pathogens, and AI is proving invaluable in identifying broad-spectrum antivirals and antibiotics.\n\n**Examples of Recent Progress (Illustrative):**\n\n*   **Insilico Medicine** has advanced AI-discovered drugs for fibrosis and cancer into clinical trials.\n*   **Recursion Pharmaceuticals** uses AI and automated experiments to identify novel drug candidates for rare diseases.\n*   Numerous biotech startups are leveraging generative AI to design novel molecules for various therapeutic areas.\n\nIn summary, drug discovery is rapidly evolving from a trial-and-error process to a more precise, data-driven, and AI-accelerated discipline. The integration of AI with novel therapeutic modalities and advanced experimental platforms is leading to faster identification of potential treatments and a more personalized approach to medicine.\n\n ### Session: compaction_demo\n\nUser > Tell me more about the second development you found.\ngemini-2.5-flash-lite >  You're likely referring to **\"Advances in Target Identification\"** from my previous answer. This is a really crucial area in drug discovery because **finding the right target is the first essential step in developing any new medicine.**\n\nHere's a deeper dive into why advances in target identification are so important and what's happening in this space:\n\n**The Challenge of Target Identification:**\n\n*   **Complexity of Biology:** Our bodies are incredibly complex systems. Diseases often arise from intricate disruptions in multiple biological pathways, involving many different proteins, genes, and molecules.\n*   **\"Undruggable\" Targets:** For a long time, many proteins that were known to play a role in disease were considered \"undruggable.\" This could be because:\n    *   They lacked suitable binding pockets for traditional drug molecules.\n    *   They were located in hard-to-reach parts of the cell.\n    *   They were essential for normal cellular function, making it difficult to target them without causing significant side effects.\n    *   They were regulatory proteins rather than enzymes, making them harder to inhibit directly.\n*   **Lack of Understanding:** For many diseases, particularly chronic and complex ones like neurodegenerative disorders, we still don't fully understand the precise molecular mechanisms driving the disease. This makes it hard to pinpoint the most effective targets for intervention.\n\n**How Recent Advances are Changing the Game:**\n\n1.  **AI and Machine Learning for Data Analysis:**\n    *   **'Omics' Data Integration:** This is a cornerstone. AI can sift through massive datasets from genomics (DNA), transcriptomics (RNA), proteomics (proteins), and metabolomics (metabolites). By identifying patterns and correlations across these different layers of biological information, AI can:\n        *   Pinpoint genes or proteins that are consistently dysregulated in disease states.\n        *   Discover novel pathways involved in disease progression.\n        *   Identify the most critical nodes in a disease network that, if targeted, could have the most significant impact.\n    *   **Literature Mining:** AI can scan millions of scientific papers, patents, and clinical trial results to identify emerging trends, connections, and potential targets that human researchers might miss.\n    *   **Predicting Target \"Druggability\":** AI models are being trained to assess the likelihood that a newly identified target can be effectively modulated by a drug, saving researchers time and resources.\n\n2.  **Tackling \"Undruggable\" Targets:**\n    *   **New Chemical Modalities:** As mentioned earlier, technologies like PROTACs (Proteolysis Targeting Chimeras) and molecular glues are specifically designed to interact with proteins that were previously difficult to drug. These don't inhibit a protein's function directly but rather \"tag\" it for degradation by the cell's natural waste disposal system. This opens up a whole new class of targets.\n    *   **Structural Biology Advances:** Techniques like cryo-electron microscopy (cryo-EM) allow scientists to visualize complex protein structures at near-atomic resolution. This detailed understanding is crucial for designing drugs that can precisely bind to these targets. AI is also assisting in the interpretation of these complex structural data.\n\n3.  **Personalized Target Identification:**\n    *   **Genomic Profiling:** With the decreasing cost of genetic sequencing, it's becoming standard practice to analyze a patient's genome. AI can then compare a patient's genetic makeup to disease databases to identify specific mutations or variations that might make them more susceptible or indicate a particular therapeutic pathway.\n    *   **Biomarker Discovery:** AI can analyze patient data to identify specific molecules (biomarkers) in the blood, tissues, or even breath that are indicative of a particular disease or its progression. These biomarkers can then serve as targets or be used to stratify patients for targeted therapies.\n\n**Why is this Development So Significant?**\n\n*   **Faster Drug Development:** If you can accurately identify the right target early on, you drastically reduce the chances of pursuing dead-end drug candidates. This accelerates the entire drug discovery pipeline.\n*   **More Effective Therapies:** Targeting the root cause of a disease, rather than just managing symptoms, leads to more effective and potentially curative treatments.\n*   **Treatment for Previously Untreatable Diseases:** By opening up new classes of targets, we have a better chance of developing therapies for diseases that currently have no effective treatments.\n*   **Personalized Medicine:** Identifying targets specific to an individual or a small group of patients allows for the development of highly tailored and precise medicines, maximizing efficacy and minimizing side effects.\n\nIn essence, advances in target identification, heavily driven by AI and new chemical/biological tools, are like finding the precise key for a very specific lock. It's about moving beyond educated guesses to data-driven certainty in the initial, critical stages of discovering new medicines.\n\n ### Session: compaction_demo\n\nUser > Who are the main companies involved in that?\ngemini-2.5-flash-lite >  The landscape of companies involved in advanced target identification is diverse, spanning large pharmaceutical giants, specialized biotech startups, and AI-focused technology providers. Here are some of the key players and types of companies involved:\n\n**1. Large Pharmaceutical Companies (The \"Big Pharma\"):**\n\nThese established companies have the resources for massive R&D efforts and are increasingly integrating AI and advanced technologies into their drug discovery pipelines. They often collaborate with or acquire smaller innovative companies.\n\n*   **Pfizer:** Actively uses AI for target identification and validation, often focusing on oncology and rare diseases.\n*   **Novartis:** Has significant AI initiatives, including partnerships and internal teams dedicated to leveraging data and machine learning for target discovery and drug development.\n*   **Roche (Genentech):** A leader in personalized medicine, Roche heavily relies on genomics and AI to identify targets for cancer and other diseases.\n*   **Merck & Co. / MSD:** Investing heavily in AI and computational biology to accelerate their R&D, including target identification.\n*   **AstraZeneca:** Uses AI across its drug discovery process, with a strong focus on areas like respiratory diseases, oncology, and cardiovascular diseases.\n*   **Bristol Myers Squibb (BMS):** Employs AI and data science for target identification and exploring complex disease mechanisms.\n\n**2. AI-Powered Drug Discovery Companies (Biotech Startups & Scale-ups):**\n\nThese companies are often founded with AI at their core, aiming to disrupt traditional drug discovery by leveraging computational approaches from the ground up.\n\n*   **Recursion Pharmaceuticals:** Uses AI and automated experimentation to map human cellular biology and identify drug targets and therapies, particularly for rare genetic diseases.\n*   **Insilico Medicine:** A prominent player using generative AI to design novel molecules and identify targets for various diseases, including fibrosis and oncology. They have advanced their AI-discovered candidates into clinical trials.\n*   **BenevolentAI:** Employs AI to analyze vast amounts of biomedical data to uncover novel drug targets and potential therapeutic approaches, with a focus on areas like neurodegenerative diseases and oncology.\n*   **Exscientia:** Develops AI platforms for drug design and target identification, aiming to accelerate the R&D process. They have a number of collaborations and clinical-stage programs.\n*   **Atomwise:** Uses deep learning for structure-based drug design, which indirectly aids in target identification by predicting how molecules might interact with potential targets.\n*   **Schr√∂dinger:** While known for its physics-based computational platforms for drug discovery, Schr√∂dinger also uses these tools to aid in target validation and understanding.\n\n**3. AI and Data Analytics Technology Providers:**\n\nThese companies provide the underlying AI, machine learning, and data infrastructure that drug discovery companies utilize.\n\n*   **Google (Verily / Google Health):** Through its life sciences divisions, Google is developing AI tools for various aspects of healthcare and drug discovery, including target identification and analysis of complex biological data.\n*   **Microsoft (Microsoft Cloud for Healthcare):** Provides cloud infrastructure and AI tools that enable researchers and biotech companies to build and deploy their own AI models for drug discovery.\n*   **NVIDIA:** Their powerful GPUs and AI software platforms (like Clara) are essential for the computational heavy lifting required for AI-driven drug discovery, including target identification and molecular modeling.\n*   **Palantir Technologies:** While not exclusively a drug discovery company, their data integration and analytics platforms are used by pharmaceutical companies to manage and derive insights from large, complex datasets, which can include target identification efforts.\n\n**4. Academic and Research Institutions:**\n\nUniversities and research institutes are often at the forefront of discovering novel biological targets and developing foundational AI methodologies. They frequently publish their findings and collaborate with industry.\n\n*   **Broad Institute of MIT and Harvard:** A leading center for genomics and computational biology, driving significant discoveries in target identification.\n*   **Various University Labs:** Countless university research labs worldwide are dedicated to unraveling disease mechanisms and identifying novel therapeutic targets, often publishing their breakthroughs.\n\n**Key Trends in Company Involvement:**\n\n*   **Collaborations and Partnerships:** It's very common for large pharma companies to partner with AI-focused biotechs to access specialized expertise and technology.\n*   **Acquisitions:** Large pharma companies often acquire promising AI-driven startups to bring their technologies and pipelines in-house.\n*   **Platform Companies:** Many AI drug discovery companies position themselves as \"platform\" companies, meaning their technology can be applied to a wide range of diseases and targets.\n\nThe field is highly dynamic, with new players emerging and existing ones evolving rapidly. The common thread is the increasing reliance on sophisticated computational tools and data analysis to find the most promising starting points for new medicines.\n","output_type":"stream"}],"execution_count":15},{"cell_type":"code","source":"# Get the final session state\nfinal_session = await session_service.get_session(\n    app_name=research_runner_compacting.app_name,\n    user_id=USER_ID,\n    session_id=\"compaction_demo\",\n)\n\nprint(\"--- Searching for Compaction Summary Event ---\")\nfound_summary = False\nfor event in final_session.events:\n    # Compaction events have a 'compaction' attribute\n    if event.actions and event.actions.compaction:\n        print(\"\\n‚úÖ SUCCESS! Found the Compaction Event:\")\n        print(f\"  Author: {event.author}\")\n        print(f\"\\n Compacted information: {event}\")\n        found_summary = True\n        break\n\nif not found_summary:\n    print(\n        \"\\n‚ùå No compaction event found. Try increasing the number of turns in the demo.\"\n    )","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:57:40.985357Z","iopub.execute_input":"2025-11-12T08:57:40.986166Z","iopub.status.idle":"2025-11-12T08:57:40.996351Z","shell.execute_reply.started":"2025-11-12T08:57:40.986141Z","shell.execute_reply":"2025-11-12T08:57:40.995681Z"}},"outputs":[{"name":"stdout","text":"--- Searching for Compaction Summary Event ---\n\n‚úÖ SUCCESS! Found the Compaction Event:\n  Author: user\n\n Compacted information: model_version=None content=None grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='0d2b58e8-6f5f-4ad5-b8d2-630ad7d17f5d' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction={'start_timestamp': 1762937815.968627, 'end_timestamp': 1762937824.850903, 'compacted_content': {'parts': [{'function_call': None, 'code_execution_result': None, 'executable_code': None, 'file_data': None, 'function_response': None, 'inline_data': None, 'text': 'The conversation began with the user asking for the latest news on AI in healthcare. The AI agent provided a comprehensive overview, highlighting advancements in drug discovery, diagnostic imaging, predictive analytics, virtual assistants, robotics, and administrative efficiency. Key trends like regulatory scrutiny, data interoperability, clinician adoption, explainable AI, and AI for mental health were also discussed.\\n\\nThe user then specifically inquired about new developments in drug discovery, prompting the AI to elaborate on the role of AI in molecule design, predictive modeling, clinical trial optimization, and target identification. The AI also mentioned new therapeutic modalities like RNA therapeutics, gene editing, and PROTACs, as well as the role of automation and organoids.\\n\\nFinally, the user asked for more information about \"Advances in Target Identification.\" The AI agent explained the challenges in this area, such as biological complexity and the existence of \"undruggable\" targets. It then detailed how AI and machine learning are being used to analyze vast \\'omics\\' data, mine literature, and predict target druggability. The agent also touched upon new chemical modalities (PROTACs, molecular glues) and structural biology advances that are helping to tackle previously difficult targets. Furthermore, the conversation highlighted how personalized target identification through genomic profiling and biomarker discovery is becoming more feasible. The AI concluded by emphasizing the significance of these advances in accelerating drug development, creating more effective therapies, treating previously untreatable diseases, and enabling personalized medicine.', 'thought': None, 'thought_signature': None, 'video_metadata': None}], 'role': 'model'}}, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='747cce96-7afe-4bf8-8992-1e8dd42b3707' timestamp=1762937831.998579\n","output_type":"stream"}],"execution_count":16},{"cell_type":"code","source":"# Define scope levels for state keys (following best practices)\nUSER_NAME_SCOPE_LEVELS = (\"temp\", \"user\", \"app\")\n\n\n# This demonstrates how tools can write to session state using tool_context.\n# The 'user:' prefix indicates this is user-specific data.\ndef save_userinfo(\n    tool_context: ToolContext, user_name: str, country: str\n) -> Dict[str, Any]:\n    \"\"\"\n    Tool to record and save user name and country in session state.\n\n    Args:\n        user_name: The username to store in session state\n        country: The name of the user's country\n    \"\"\"\n    # Write to session state using the 'user:' prefix for user data\n    tool_context.state[\"user:name\"] = user_name\n    tool_context.state[\"user:country\"] = country\n\n    return {\"status\": \"success\"}\n\n\n# This demonstrates how tools can read from session state.\ndef retrieve_userinfo(tool_context: ToolContext) -> Dict[str, Any]:\n    \"\"\"\n    Tool to retrieve user name and country from session state.\n    \"\"\"\n    # Read from session state\n    user_name = tool_context.state.get(\"user:name\", \"Username not found\")\n    country = tool_context.state.get(\"user:country\", \"Country not found\")\n\n    return {\"status\": \"success\", \"user_name\": user_name, \"country\": country}\n\n\nprint(\"‚úÖ Tools created.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:58:13.299772Z","iopub.execute_input":"2025-11-12T08:58:13.300068Z","iopub.status.idle":"2025-11-12T08:58:13.307229Z","shell.execute_reply.started":"2025-11-12T08:58:13.300050Z","shell.execute_reply":"2025-11-12T08:58:13.306446Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Tools created.\n","output_type":"stream"}],"execution_count":17},{"cell_type":"code","source":"# Configuration\nAPP_NAME = \"default\"\nUSER_ID = \"default\"\nMODEL_NAME = \"gemini-2.5-flash-lite\"\n\n# Create an agent with session state tools\nroot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"\"\"A text chatbot.\n    Tools for managing user context:\n    * To record username and country when provided use `save_userinfo` tool. \n    * To fetch username and country when required use `retrieve_userinfo` tool.\n    \"\"\",\n    tools=[save_userinfo, retrieve_userinfo],  # Provide the tools to the agent\n)\n\n# Set up session service and runner\nsession_service = InMemorySessionService()\nrunner = Runner(agent=root_agent, session_service=session_service, app_name=\"default\")\n\nprint(\"‚úÖ Agent with session state tools initialized!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:58:35.399416Z","iopub.execute_input":"2025-11-12T08:58:35.400090Z","iopub.status.idle":"2025-11-12T08:58:35.406795Z","shell.execute_reply.started":"2025-11-12T08:58:35.400067Z","shell.execute_reply":"2025-11-12T08:58:35.405868Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Agent with session state tools initialized!\n","output_type":"stream"}],"execution_count":18},{"cell_type":"code","source":"# Test conversation demonstrating session state\nawait run_session(\n    runner,\n    [\n        \"Hi there, how are you doing today? What is my name?\",  # Agent shouldn't know the name yet\n        \"My name is Sam. I'm from Poland.\",  # Provide name - agent should save it\n        \"What is my name? Which country am I from?\",  # Agent should recall from session state\n    ],\n    \"state-demo-session\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:58:51.502417Z","iopub.execute_input":"2025-11-12T08:58:51.503079Z","iopub.status.idle":"2025-11-12T08:58:53.791781Z","shell.execute_reply.started":"2025-11-12T08:58:51.503051Z","shell.execute_reply":"2025-11-12T08:58:53.790965Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: state-demo-session\n\nUser > Hi there, how are you doing today? What is my name?\ngemini-2.5-flash-lite >  Hello! I'm doing great, thank you for asking. I'm not sure what your name is, though. Would you like to tell me?\n\nUser > My name is Sam. I'm from Poland.\n","output_type":"stream"},{"name":"stderr","text":"WARNING:google_genai.types:Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n","output_type":"stream"},{"name":"stdout","text":"gemini-2.5-flash-lite >  It is nice to meet you, Sam! I will save your name and country.\ngemini-2.5-flash-lite >  I have saved your name and country. How can I help you further?\n\nUser > What is my name? Which country am I from?\n","output_type":"stream"},{"name":"stderr","text":"WARNING:google_genai.types:Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n","output_type":"stream"},{"name":"stdout","text":"gemini-2.5-flash-lite >  Your name is Sam and you are from Poland.\n","output_type":"stream"}],"execution_count":19},{"cell_type":"code","source":"# Retrieve the session and inspect its state\nsession = await session_service.get_session(\n    app_name=APP_NAME, user_id=USER_ID, session_id=\"state-demo-session\"\n)\n\nprint(\"Session State Contents:\")\nprint(session.state)\nprint(\"\\nüîç Notice the 'user:name' and 'user:country' keys storing our data!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:59:20.274062Z","iopub.execute_input":"2025-11-12T08:59:20.274954Z","iopub.status.idle":"2025-11-12T08:59:20.280749Z","shell.execute_reply.started":"2025-11-12T08:59:20.274928Z","shell.execute_reply":"2025-11-12T08:59:20.279708Z"}},"outputs":[{"name":"stdout","text":"Session State Contents:\n{'user:name': 'Sam', 'user:country': 'Poland'}\n\nüîç Notice the 'user:name' and 'user:country' keys storing our data!\n","output_type":"stream"}],"execution_count":20},{"cell_type":"code","source":"# Start a completely new session - the agent won't know our name\nawait run_session(\n    runner,\n    [\"Hi there, how are you doing today? What is my name?\"],\n    \"new-isolated-session\",\n)\n\n# Expected: The agent won't know the name because this is a different session","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:59:40.830077Z","iopub.execute_input":"2025-11-12T08:59:40.830350Z","iopub.status.idle":"2025-11-12T08:59:41.484472Z","shell.execute_reply.started":"2025-11-12T08:59:40.830330Z","shell.execute_reply":"2025-11-12T08:59:41.483710Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: new-isolated-session\n\nUser > Hi there, how are you doing today? What is my name?\ngemini-2.5-flash-lite >  Hello! I'm doing great. I can't recall your name just yet. Can you remind me of it?\n\n","output_type":"stream"}],"execution_count":21},{"cell_type":"code","source":"# Check the state of the new session\nsession = await session_service.get_session(\n    app_name=APP_NAME, user_id=USER_ID, session_id=\"new-isolated-session\"\n)\n\nprint(\"New Session State:\")\nprint(session.state)\n\n# Note: Depending on implementation, you might see shared state here.\n# This is where the distinction between session-specific and user-specific state becomes important.","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T08:59:59.310261Z","iopub.execute_input":"2025-11-12T08:59:59.310602Z","iopub.status.idle":"2025-11-12T08:59:59.315980Z","shell.execute_reply.started":"2025-11-12T08:59:59.310578Z","shell.execute_reply":"2025-11-12T08:59:59.315208Z"}},"outputs":[{"name":"stdout","text":"New Session State:\n{'user:name': 'Sam', 'user:country': 'Poland'}\n","output_type":"stream"}],"execution_count":22},{"cell_type":"code","source":"# Clean up any existing database to start fresh (if Notebook is restarted)\nimport os\n\nif os.path.exists(\"my_agent_data.db\"):\n    os.remove(\"my_agent_data.db\")\nprint(\"‚úÖ Cleaned up old database files\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T09:00:17.271936Z","iopub.execute_input":"2025-11-12T09:00:17.272646Z","iopub.status.idle":"2025-11-12T09:00:17.278481Z","shell.execute_reply.started":"2025-11-12T09:00:17.272620Z","shell.execute_reply":"2025-11-12T09:00:17.277316Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Cleaned up old database files\n","output_type":"stream"}],"execution_count":23}]}